C-286 An act to amend the Controlled Drugs and Substances Act and the Good and Drugs Act. Discuss proposed amendments related to the regulation of psilocybin and psilocin for medical purposes, including their treatment under the Narcotic Control Regulations and priority review of eligible new drug submissions.Read more
Yash Nanda · Policy advisor, Prime Minister's Office (PMO)
Cosmetic Regulations: Interest in the modernization of the cosmetic Regulations and the development of guidelines relating to the manufacture, packaging, labelling, advertising, sale, exportations and importation of cosmetic products.Read more
Jennifer Miller · Assistant Secretary to the Cabinet, Social Development Policy, Privy Council Office (PCO)
Legislative Renewal for the Food and Drugs Act, including the development of the Consumer Health Products FrameworkRead more
Cosmetic Regulations: Interest in the modernization of the cosmetic Regulations and the development of guidelines relating to the manufacture, packaging, labelling, advertising, sale, exportations and importation of cosmetic products.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.